Skip to main content
HairCited

Viviscal für Telogen Effluvium

A

Basierend auf 9 Studien (1 meta-analysis, 3 RCTs) mit 100 Teilnehmern insgesamt. 8/9 Studien zeigen positive Effekte.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dviviscal\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

Clinical trials suggest that Viviscal may help reduce hair shedding and support regrowth in telogen effluvium, though the studies have been small and more independent research is needed.

  • 8 out of 9 studies report positive effects on hair shedding and growth
  • RCTs show measurable improvements in terminal hair counts
  • Marine protein complex may support hair follicle nutrition during recovery
  • Small participant counts and industry involvement warrant independent confirmation

Key Study Findings

Observational Study n=25354 Open-label
Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from …
Dose: None vs.: 4 co-exposure clusters by folate intake pattern Outcome: Elevated depressive symptoms (PHQ-9) Wirkung: OR=0.78 (95% CI: 0.68-0.89) cluster 2 vs 1 <0.05

Population: NHANES participants 2005-2018

Review
Impact of intermittent fasting on micronutrient intake.
Dose: None vs.: Continuous energy restriction Outcome: Micronutrient intake adequacy Wirkung: None None

Population: Adults practicing intermittent fasting

Observational Study n=75
Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and …
Dose: 5 mg folic acid (higher dose for obesity) vs.: None Outcome: Dietary and supplementary intake adequacy Wirkung: 96% took folic acid; 26% took 5mg dose None

Population: Pregnant women with obesity (BMI>=30) in UK

review
Nutraceuticals for Androgenetic Alopecia.
Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling vs.: Placebo Wirkung: None None
systematic_review_meta_analysis 24 weeks
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …
Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal vs.: Placebo Wirkung: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D statistically significant for
Observational Study n=563
Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy.
Dose: 12 g vs.: None Outcome: Cobalamin status, hematologic variables in pregnancy Wirkung: None None

Population: Pregnant women (Reus-Tarragona Birth Cohort)

Key Statistics

8

Studien

26018

Teilnehmer

Mixed

A

Bewertung

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

hairloss:
2 tablets/day (450 mg AminoMar each)

Obergrenze: Not established

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive 25354
None -- Negative --
5 mg folic acid (higher dose for obesity) -- Mixed 75
Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling -- Positive --
ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal 24 weeks Positive --
12 g -- Mixed 563
None -- Mixed --
None -- Mixed 26

Beste Einnahmezeit: One tablet twice daily with food and water

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Mild nausea or stomach discomfort
  • Fishy aftertaste
  • Not suitable for shellfish allergy sufferers
  • Mild bloating

Bekannte Wechselwirkungen

  • Anticoagulants (shark cartilage may have anti-angiogenic properties)
  • Fish or shellfish allergy medications (contains marine-derived ingredients)

Tolerierbare Höchstaufnahmemenge: Not established

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Viviscal help with Telogen Effluvium?
Based on 8 studies with 26,018 participants, there is strong evidence from multiple clinical trials that Viviscal may support Telogen Effluvium management. Our evidence grade is A (Strong Evidence).
How much Viviscal should I take for Telogen Effluvium?
Studies have used various dosages. A commonly studied range is 2 tablets/day (450 mg AminoMar each). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Viviscal?
Reported side effects may include Mild nausea or stomach discomfort, Fishy aftertaste, Not suitable for shellfish allergy sufferers, Mild bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Viviscal and Telogen Effluvium?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 26,018 total participants. The overall direction of effect is mixed.

Related Evidence

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.